| ONS Shares Outstanding History Table | ||||||||||||||||||||||||||
Below is a table of the ONS shares outstanding history going back to 6/13/2016:
Also see: ONS Market Cap History ONS YTD Return |
As of 8/10/2018 Oncobiologics has 72.20 million ONS shares outstanding. Investors often track the ONS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ONS share count trends over time, with 12 historical shares outstanding datapoints presented, dating back to 6/13/2016.

| ONS Shares Outstanding History Table | ||||||||||||||||||||||||||
Below is a table of the ONS shares outstanding history going back to 6/13/2016:
Also see: ONS Market Cap History ONS YTD Return |
| ONS Shares Outstanding History Chart | |||||||||||||||||||||||||||
ONS Historical Shares Outstanding: +73.52% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||
| ONS Stock Price Chart |
| About Outlook Therapeutics Inc |
| Oncobiologics is a clinical-stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. Co. focuses on monoclonal antibodies, or mAbs, in the disease areas of immunology and oncology. A mAb is a type of protein that is produced by a single clone of cells or cell line and made to bind to a specific substance in the body. Co. has two product candidates: ONS-3010, a biosimilar to adalimumab (Humira®), and ONS-1045, a biosimilar to bevacizumab (Avastin®). We show 12 historical shares outstanding datapoints in our coverage of ONS's shares outstanding history. Understanding the changing numbers of ONS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ONS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ONS by allowing them to research ONS shares outstanding history as well as any other stock in our coverage universe. |
| ONS Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| ONS Share Performance |
| Shares Outstanding Peers |
| Oncobiologics (ONS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ONTX Shares Outstanding History ONVO Shares Outstanding History OPCH Shares Outstanding History OPGN Shares Outstanding History OPHT Shares Outstanding History OPK Shares Outstanding History OPNT Shares Outstanding History OPTN Shares Outstanding History ORGO Shares Outstanding History ORGS Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.